117 related articles for article (PubMed ID: 32417912)
1. Circulating CD19+CD24hiCD38hi regulatory B cells as biomarkers of response to methotrexate in early rheumatoid arthritis.
Fortea-Gordo P; Villalba A; Nuño L; Santos-Bórnez MJ; Peiteado D; Monjo I; Puig-Kröger A; Sánchez-Mateos P; Martín-Mola E; Balsa A; Miranda-Carús ME
Rheumatology (Oxford); 2020 Oct; 59(10):3081-3091. PubMed ID: 32417912
[TBL] [Abstract][Full Text] [Related]
2. PD-L1
Zacca ER; Onofrio LI; Acosta CDV; Ferrero PV; Alonso SM; Ramello MC; Mussano E; Onetti L; Cadile II; Stancich MI; Taboada Bonfanti MC; Montes CL; Acosta Rodríguez EV; Gruppi A
Front Immunol; 2018; 9():2241. PubMed ID: 30327652
[No Abstract] [Full Text] [Related]
3. Percentage of Peripheral CD19+CD24hiCD38hi Regulatory B Cells in Neonatal Sepsis Patients and Its Functional Implication.
Pan X; Ji Z; Xue J
Med Sci Monit; 2016 Jul; 22():2374-8. PubMed ID: 27389933
[TBL] [Abstract][Full Text] [Related]
4. Two populations of circulating PD-1hiCD4 T cells with distinct B cell helping capacity are elevated in early rheumatoid arthritis.
Fortea-Gordo P; Nuño L; Villalba A; Peiteado D; Monjo I; Sánchez-Mateos P; Puig-Kröger A; Balsa A; Miranda-Carús ME
Rheumatology (Oxford); 2019 Sep; 58(9):1662-1673. PubMed ID: 31056653
[TBL] [Abstract][Full Text] [Related]
5. CD39 positive regulatory T cell frequency as a biomarker of treatment response to methotrexate in rheumatoid arthritis.
Gupta V; Katiyar S; Singh A; Misra R; Aggarwal A
Int J Rheum Dis; 2018 Aug; 21(8):1548-1556. PubMed ID: 30146748
[TBL] [Abstract][Full Text] [Related]
6. Association of a Type 2-Polarized T Cell Phenotype With Methotrexate Nonresponse in Patients With Rheumatoid Arthritis.
Slauenwhite D; McAlpine SM; Hanly JG; Malik A; Haidl ID; Marshall JS; Issekutz TB
Arthritis Rheumatol; 2020 Jul; 72(7):1091-1102. PubMed ID: 32039570
[TBL] [Abstract][Full Text] [Related]
7. Methrotexate Treatment Inmunomodulates Abnormal Cytokine Expression by T CD4 Lymphocytes Present in DMARD-Naïve Rheumatoid Arthritis Patients.
Monserrat Sanz J; Bohórquez C; Gómez AM; Movasat A; Pérez A; Ruíz L; Diaz D; Sánchez AI; Albarrán F; Sanz I; Álvarez-Mon M
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961930
[TBL] [Abstract][Full Text] [Related]
8. An immunological biomarker to predict MTX response in early RA.
Ponchel F; Goëb V; Parmar R; El-Sherbiny Y; Boissinot M; El Jawhari J; Burska A; Vital EM; Harrison S; Conaghan PG; Hensor E; Emery P
Ann Rheum Dis; 2014 Nov; 73(11):2047-53. PubMed ID: 23989988
[TBL] [Abstract][Full Text] [Related]
9. CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation.
Flores-Borja F; Bosma A; Ng D; Reddy V; Ehrenstein MR; Isenberg DA; Mauri C
Sci Transl Med; 2013 Feb; 5(173):173ra23. PubMed ID: 23427243
[TBL] [Abstract][Full Text] [Related]
10. Soluble OX40L is associated with presence of autoantibodies in early rheumatoid arthritis.
Laustsen JK; Rasmussen TK; Stengaard-Pedersen K; Hørslev-Petersen K; Hetland ML; Østergaard M; Junker P; Hvid M; Deleuran B
Arthritis Res Ther; 2014 Oct; 16(5):474. PubMed ID: 25359291
[TBL] [Abstract][Full Text] [Related]
11. Synovial Immunophenotype and Anti-Citrullinated Peptide Antibodies in Rheumatoid Arthritis Patients: Relationship to Treatment Response and Radiologic Prognosis.
Orr C; Najm A; Biniecka M; McGarry T; Ng CT; Young F; Fearon U; Veale DJ
Arthritis Rheumatol; 2017 Nov; 69(11):2114-2123. PubMed ID: 28732135
[TBL] [Abstract][Full Text] [Related]
12. Circulating anti-citrullinated peptide antibodies, cytokines and genotype as biomarkers of response to disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.
Ally MM; Hodkinson B; Meyer PW; Musenge E; Tintinger GR; Tikly M; Anderson R
BMC Musculoskelet Disord; 2015 May; 16():130. PubMed ID: 26021985
[TBL] [Abstract][Full Text] [Related]
13. The effect of methotrexate (MTX) on expression of signalling lymphocytic activation molecule (SLAM) in patients with rheumatoid arthritis (RA) and its role in the regulation of cytokine production.
Morita Y; Fukazawa T; Hirashima M; Kaga K; Kusaoi M; Morita T; Touyama S; Morita K; Takasaki Y; Hashimoto H
Scand J Rheumatol; 2006; 35(4):268-72. PubMed ID: 16882589
[TBL] [Abstract][Full Text] [Related]
14. A novel predictor of clinical response to methotrexate in patients with rheumatoid arthritis: a pilot study of in vitro T cell cytokine suppression.
Haroon N; Srivastava R; Misra R; Aggarwal A
J Rheumatol; 2008 Jun; 35(6):975-8. PubMed ID: 18464312
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine.
Kapetanovic MC; Nagel J; Nordström I; Saxne T; Geborek P; Rudin A
Vaccine; 2017 Feb; 35(6):903-908. PubMed ID: 28081972
[TBL] [Abstract][Full Text] [Related]
16. Tumour necrosis factor (TNF) production by T cell receptor-primed T lymphocytes is a target for low dose methotrexate in rheumatoid arthritis.
Hildner K; Finotto S; Becker C; Schlaak J; Schirmacher P; Galle PR; Märker-Hermann E; Neurath MF
Clin Exp Immunol; 1999 Oct; 118(1):137-46. PubMed ID: 10540171
[TBL] [Abstract][Full Text] [Related]
17. Reduced numbers of regulatory B cells are negatively correlated with disease activity in patients with new-onset rheumatoid arthritis.
Ma L; Liu B; Jiang Z; Jiang Y
Clin Rheumatol; 2014 Feb; 33(2):187-95. PubMed ID: 23949637
[TBL] [Abstract][Full Text] [Related]
18. Assessment of global DNA methylation in peripheral blood cell subpopulations of early rheumatoid arthritis before and after methotrexate.
de Andres MC; Perez-Pampin E; Calaza M; Santaclara FJ; Ortea I; Gomez-Reino JJ; Gonzalez A
Arthritis Res Ther; 2015 Aug; 17(1):233. PubMed ID: 26330155
[TBL] [Abstract][Full Text] [Related]
19. Seropositivity-Dependent Association between LINE-1 Methylation and Response to Methotrexate Therapy in Early Rheumatoid Arthritis Patients.
Ravaei A; Pulsatelli L; Assirelli E; Meliconi R; Ciaffi J; Gremese E; Tolusso B; Salvarani C; Govoni M; Rubini M
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360249
[TBL] [Abstract][Full Text] [Related]
20. Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort.
Lukas C; Mary J; Debandt M; Daïen C; Morel J; Cantagrel A; Fautrel B; Combe B
Arthritis Res Ther; 2019 Nov; 21(1):243. PubMed ID: 31730497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
